Letter: vedolizumab or a second anti-TNF-no difference in efficacy for primary biologic failures with IBD.
作者信息
Demarzo Maria Giulia, Bodini Giorgia, Vanello Mattia, Martini Martina, Giannini Edoardo G
机构信息
Gastroenterology Unit, Department of Internal Medicine, University of Genoa, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
出版信息
Aliment Pharmacol Ther. 2021 May;53(9):1044-1045. doi: 10.1111/apt.16301.
PMID:33831237
Abstract
摘要
Zotero 插件